These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22811992)

  • 1. Tackling neglected areas of oncology with provocative questions.
    Estey MP
    Clin Chem; 2012 Jun; 58(6):1071-2. PubMed ID: 22811992
    [No Abstract]   [Full Text] [Related]  

  • 2. Emphasizing the provocative.
    Rose S
    Cancer Discov; 2012 Nov; 2(11):968. PubMed ID: 23148360
    [No Abstract]   [Full Text] [Related]  

  • 3. The NCI Physical Sciences - Oncology Network.
    Zahir N
    Trends Cancer; 2018 Apr; 4(4):e1-e6. PubMed ID: 29656775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Private Funding for Pancreatic Cancer Research: More Than a Chip Shot.
    Hendifar AE; Davies L; Tuli R
    Gastroenterology; 2017 Apr; 152(5):918-921.e2. PubMed ID: 28259790
    [No Abstract]   [Full Text] [Related]  

  • 5. Science funding: Provocative questions in cancer research.
    Varmus H; Harlow E
    Nature; 2012 Jan; 481(7382):436-7. PubMed ID: 22281578
    [No Abstract]   [Full Text] [Related]  

  • 6. NCI Posts New "Provocative Questions".
    Cancer Discov; 2015 Jun; 5(6):569-70. PubMed ID: 25929849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is smaller better?
    Wallner PE
    J Am Coll Radiol; 2004 Dec; 1(12):904-5. PubMed ID: 17411730
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventional oncology: perspectives on current scholarly productivity and potential for future growth.
    Becker GJ
    Radiology; 2010 Nov; 257(2):309-12. PubMed ID: 20959543
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 10. Decade in review-funding in cancer research: National Cancer Institute awards-a work in progress.
    Fojo T; Giannakakou P
    Nat Rev Clin Oncol; 2014 Nov; 11(11):634-6. PubMed ID: 25311348
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of cancer research bureaucracy on innovation, costs, and patient care.
    Steensma DP; Kantarjian HM
    J Clin Oncol; 2014 Feb; 32(5):376-8. PubMed ID: 24395852
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer experts unveil wishlist for US government 'moonshot'.
    Ledford H
    Nature; 2016 Sep; 537(7620):288-9. PubMed ID: 27629616
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
    Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
    J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Patel JD; Krilov L; Adams S; Aghajanian C; Basch E; Brose MS; Carroll WL; de Lima M; Gilbert MR; Kris MG; Marshall JL; Masters GA; O'Day SJ; Polite B; Schwartz GK; Sharma S; Thompson I; Vogelzang NJ; Roth BJ
    J Clin Oncol; 2014 Jan; 32(2):129-60. PubMed ID: 24327669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer research funding in Europe low compared with U.S., survey finds.
    Illman J
    J Natl Cancer Inst; 2005 May; 97(10):713-4. PubMed ID: 15900040
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustaining the engine of U.S. biomedical discovery.
    Heinig SJ; Krakower JY; Dickler HB; Korn D
    N Engl J Med; 2007 Sep; 357(10):1042-7. PubMed ID: 17804852
    [No Abstract]   [Full Text] [Related]  

  • 17. The sound and the fury: financial conflicts of interest in oncology.
    Djulbegovic B; Angelotta C; Knox KE; Bennett CL
    J Clin Oncol; 2007 Aug; 25(24):3567-9. PubMed ID: 17704401
    [No Abstract]   [Full Text] [Related]  

  • 18. The flat-funding years and the National Cancer Institute: consequences for cancer research.
    Hitt E
    Mol Oncol; 2008 Dec; 2(4):290-2. PubMed ID: 19383350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer Research.
    Vose JM
    Oncology (Williston Park); 2015 Sep; 29(9):613, 615. PubMed ID: 26391037
    [No Abstract]   [Full Text] [Related]  

  • 20. Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.
    Begum M; Lewison G; Lawler M; Sullivan R
    Eur J Cancer; 2018 Sep; 100():75-84. PubMed ID: 30014883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.